COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,001 Articles (22,627 medRxiv, 8,374 bioRxiv)

Most recent first Previous |  Page 1830: Articles 18291-18300  | Next

Stringency of the containment measures in response to COVID-19 inversely correlates with the overall disease occurrence over the epidemic wave
Mezencev, R., Klement, C.
10.1101/2021.01.26.21250501 — Posted: 2021-01-29
SARS-CoV-2 seropositivity and subsequent infection risk in healthy young adults: a prospective cohort study
Letizia, A. G., Ge, Y., Vangeti, S., Goforth, C., Weir, D. L., Kuzmina, N. A., Chen, H. W., Ewing, D., Soares-Schanoski, A., George, M.-C., Graham, W. D., Jones, F., Bharaj, P., Lizewski, R. A., Lizewski, S. A., Marayag, J., Marjanovic,, N., Miller, C., Mofsowitz, S., Nair, V. D., Nunez, E., Parent, D. M., Porter, C. K., Santa Ana, E., Schilling, M., Stadlbauer, D., Sugiharto, V., Termini, M. S., Sun, P., Tracy, R. P., Krammer, F., Bukreyev, A., Irene, R., Sealfon, S. C.
10.1101/2021.01.26.21250535 — Posted: 2021-01-29
Covid-19 positive test cycle threshold trends predict covid-19 mortality in Rhode Island
Bostom, A., Eaton, C. B., Kenyon, T.
10.1101/2021.01.26.21250557 — Posted: 2021-01-29
The E484K mutation in the SARS-CoV-2 spike protein reduces but does not abolish neutralizing activity of human convalescent and post-vaccination sera.
Jangra, S., Ye, C., Rathnasinghe, R., Stadlbauer, D., Personalized Virology Initiative (PVI) Study Group, , Krammer, F., Simon, V., Martinez-Sobrido, L., Garcia-Sastre, A., Schotsaert, M.
10.1101/2021.01.26.21250543 — Posted: 2021-01-29
SARS-CoV-2 infection and transmission in school settings during the second wave in Berlin, Germany: a cross-sectional study
Theuring, S., Thielecke, M., van Loon, W., Hommes, F., Huelso, C., von der Haar, A., Koerner, J., Schmidt, M., Boehringer, F., Mall, M. A., Rosen, A., von Kalle, C., Kirchberger, V., Kurth, T., Seybold, J., Mockenhaupt, F. P., BECOSS Study Group
10.1101/2021.01.27.21250517 — Posted: 2021-01-29 Discussion: Offsite
Evaluation of spike protein antigens for SARS-CoV-2 serology
Jagtap, S., K, R., Valloly, P., Sharma, R., Maurya, S., Gaigore, A., Ardhya, C., Biligi, D. S., Desiraju, B. K., Natchu, U. C. M., Saini, D. K., Roy, R.
10.1101/2021.01.27.21250382 — Posted: 2021-01-29
THE AIRBORNE CONTAGIOUSNESS OF RESPIRATORY VIRUSES: A COMPARATIVE ANALYSIS AND IMPLICATIONS FOR MITIGATION
Mikszewski, A., Stabile, L., Buonanno, G., Morawska, L.
10.1101/2021.01.26.21250580 — Posted: 2021-01-29
Lumipulse G SARS-CoV-2 Ag Assay Evaluation for SARS-CoV-2 Antigen Detection Using 594 Nasopharyngeal Swab Samples from Different Testing Groups
Menchinelli, G., Bordi, L., Marzialiotti, F., Palucci, I., Capobianchi, M. R., Sberna, G., Lalle, E., Romano, L., De Angelis, G., Marchetti, S., Sanguinetti, M., Cattani, P., Posteraro, B.
10.1101/2021.01.26.21250533 — Posted: 2021-01-29
Disentangling the association of hydroxychloroquine treatment with mortality in Covid-19 hospitalized patients through Hierarchical Clustering
Di Castelnuovo, A., Gialluisi, A., The COVID-19 RISK and Treatments (CORIST) Collaboration, , Iacoviello, L.
10.1101/2021.01.27.21250238 — Posted: 2021-01-29
Post-Mendelian genetic model in COVID-19
Picchiotti, N., Benetti, E., Fallerini, C., Daga, S., Baldassarri, M., Fava, F., Zguro, K., Valentino, F., Doddato, G., Giliberti, A., Tita, R., Amitrano, S., Bruttini, M., Di Sarno, L., Iuso, N., Alaverdian, D., Beligni, G., Croci, S., Meloni, I., Pinto, A. M., Gabbi, C., Ceri, S., Esposito, A., Pinoli, P., Crawley, F. P., Frullanti, E., Mari, F., GEN-COVID Multicenter Study, , Gori, M., Renieri, A., Furini, S.
10.1101/2021.01.27.21250593 — Posted: 2021-01-29

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).